NPI registry status
Active
2026 NPPES data Otolaryngology Physician NPI 1386635415 M.D.
Verify on CMS → Jay Chavda, M.D.
Otolaryngology Physician in Houston, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,060 in Otolaryngology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 473 beneficiaries · Otolaryngology Physician avg: 536
Industry payments
$1.8K
20 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Jay Chavda, M.D. filed 3,298 Medicare Part D claims in 2024 as an Otolaryngology Physician in Houston, Texas.
- 3K
- Part D claims, 2024
- $1.8K
- industry payments (Sunshine Act)
- ≥89th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jay Chavda, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1386635415), first enumerated 10/28/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,298 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$1.8K in reported industry payments (20 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Jay Chavda, M.D.'s individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1386635415 · Otolaryngology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1386635415
- ENUM-LEGACY 2005
- TAX-MID 11K Otolaryngology Physician
- RX-MID 3,298
- BOOK-LIGHT 787 in Texas
- PHOTO-ENUM Henry Daugherty, MD · 2005
Jay Chavda, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
3,298 ≥ 89th percentile 89% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Jay Chavda, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jay Chavda, M.D.?
Quality data not reportedPrimary specialty
Otolaryngology Physician
Medicare Part D claims
3,298 6× vs specialty avg
Specialty distribution in Texas
How Otolaryngology Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Otolaryngology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1386635415 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/28/2005 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jay Chavda, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.8K
Largest payer
Integra LifeSciences Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Jay Chavda, M.D.. To verify Jay Chavda, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,298
Total Claims
$143K
Total Drug Cost
473
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,334.367
- Total Day Supply
- 152,757
- Generic Drug Cost
- $47K
- Antibiotic Claims
- 179
Patient Demographics
- Average Patient Age
- 71.2 years
- Avg HCC Risk Score
- 1.68
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 82, 65-74: 207, 75-84: 135, 85+: 49
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jay Chavda, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Montelukast Sodium
Montelukast Sodium
674 claims
- Omeprazole
Omeprazole
521 claims
- Fluticasone Propio…
Fluticasone Propionate
398 claims
- Meloxicam
Meloxicam
365 claims
- Neomycin-Polymyxin… 253
Neomycin-Polymyxin-Hc
253 claims
- Levocetirizine Dih… 141
Levocetirizine Dihydrochloride
141 claims
- Diclofenac Sodium 107
Diclofenac Sodium
107 claims
- Xhance 90
Xhance
90 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 674 |
| Omeprazole | 521 |
| Fluticasone Propionate | 398 |
| Meloxicam | 365 |
| Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort | 253 |
| Levocetirizine Dihydrochloride | 141 |
| Diclofenac Sodium | 107 |
| Xhance Fluticasone Propionate | 90 |
| Mupirocin | 80 |
| Metoclopramide Hcl | 65 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How Jay Chavda, M.D. fits within the Otolaryngology Physician landscape nationally.
11,060
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
536
Avg Claims per Provider
Jay Chavda, M.D.'s 3,298 claims are above the specialty average of 536.
Nationwide Otolaryngology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Chavda, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otolaryngology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Chavda.
One of 787 Otolaryngology Physician providers enrolled in Texas, 5 are shown here.
Dr. Jason Acevedo
MD
Abilene, TX
Jason Adams
Jbsa Ft Sam Houston, TX
Dr. Jane Admire
MD
Dallas, TX
Dr. Robert Africa
MD
Galveston, TX
Dr. Ashley Agan
MD
Dallas, TX
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jay Chavda, M.D.'s specialty? ▼
Jay Chavda, M.D. specializes in Otolaryngology Physician and practices in Houston, Texas. Credentials: M.D..
How much does Jay Chavda, M.D. prescribe under Medicare Part D? ▼
In 2024, Jay Chavda, M.D. wrote 3,298 Medicare Part D claims totaling $143K in drug costs for 473 beneficiaries.
Where is Jay Chavda, M.D. located? ▼
Jay Chavda, M.D. is located at 7737 SOUTHWEST FWY, Houston, TX, 77074. Phone: (713) 774-2090.
What is Jay Chavda, M.D.'s NPI number? ▼
Jay Chavda, M.D.'s National Provider Identifier (NPI) is 1386635415, issued on 10/28/2005.
How many Otolaryngology Physician providers are there in the US? ▼
There are 11,060 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 536 Medicare Part D claims per year.
What drugs does Jay Chavda, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Jay Chavda, M.D.'s most frequently prescribed drugs include Montelukast Sodium, Omeprazole, Fluticasone Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jay Chavda, M.D. accept Medicare? ▼
Jay Chavda, M.D. appears in CMS Medicare data with 3,298 Part D claims and 473 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jay Chavda, M.D.'s credentials? ▼
Jay Chavda, M.D.'s NPI is 1386635415 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.